BIOASTER
Ana Delgado is a skilled research and development engineer currently working at BIOASTER since September 2015, specializing in cytometry and the development of tools for studying immune responses, host/microbiome interactions, and the characterization of alveolar macrophages and microbiota. Prior experience includes a role as a qualified technician in immunomonitoring at the Centre Léon Bérard, where participation in clinical studies on breast cancer involved analyzing innate immune responses in blood. Additionally, Ana Delgado contributed to a R&D project on skin aging at BASF BCS, managing project aspects and conducting biological studies. Educational background includes a Master 2 in Biotechnology and a Master 2 in Cellular and Molecular Biology from Pierre and Marie Curie University and Université catholique de Lyon, respectively, alongside a Licence and Master 1 in Biology from Université Claude Bernard Lyon 1.
This person is not in any offices
BIOASTER
1 followers
BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures. BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries. More information on www.bioaster.org